Source:http://linkedlifedata.com/resource/pubmed/id/14583936
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
2003-10-29
|
pubmed:abstractText |
Surgery has been the treatment of choice for localized esophageal cancer. A number of studies have investigated whether preoperative chemotherapy followed by surgery leads to an improvement in cure rates, but the individual reports have been conflicting. An explicit systematic update of the role of preoperative chemotherapy in the treatment of resectable thoracic esophageal cancer is therefore warranted.
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
1469-493X
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
CD001556
|
pubmed:dateRevised |
2009-11-3
|
pubmed:meshHeading |
pubmed-meshheading:14583936-Antineoplastic Agents,
pubmed-meshheading:14583936-Combined Modality Therapy,
pubmed-meshheading:14583936-Esophageal Neoplasms,
pubmed-meshheading:14583936-Humans,
pubmed-meshheading:14583936-Preoperative Care,
pubmed-meshheading:14583936-Quality of Life,
pubmed-meshheading:14583936-Randomized Controlled Trials as Topic
|
pubmed:year |
2003
|
pubmed:articleTitle |
Preoperative chemotherapy for resectable thoracic esophageal cancer.
|
pubmed:affiliation |
Department of Surgery, University of Western Ontario, London Health Sciences Centre, 375 South Street, Suite N345, London, Ontario, Canada, N6A 4G5. richard.malthaner@lhsc.on.ca
|
pubmed:publicationType |
Journal Article,
Review
|